Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Coherus Biosciences Inc (NASDAQ: CHRS) closed at $2.18 up 5.31% from its previous closing price of $2.07. In other words, the price has increased by $5.31 from its previous closing price. On the day, 1.5 million shares were traded. CHRS stock price reached its highest trading level at $2.19 during the session, while it also had its lowest trading level at $2.04.
Ratios:
For a deeper understanding of Coherus Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.24 and its Current Ratio is at 1.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on November 17, 2023, initiated with a Outperform rating and assigned the stock a target price of $11.
On July 24, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $12.Citigroup initiated its Buy rating on July 24, 2023, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 22 ’23 when Lanfear Dennis M sold 223,100 shares for $2.02 per share. The transaction valued at 449,770 led to the insider holds 731,693 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 247425648 and an Enterprise Value of 596412992. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.96. Its current Enterprise Value per Revenue stands at 2.318 whereas that against EBITDA is -3.149.
Stock Price History:
Over the past 52 weeks, CHRS has reached a high of $8.33, while it has fallen to a 52-week low of $1.43. The 50-Day Moving Average of the stock is -8.69%, while the 200-Day Moving Average is calculated to be -31.38%.
Shares Statistics:
For the past three months, CHRS has traded an average of 3.24M shares per day and 1861530 over the past ten days. A total of 112.22M shares are outstanding, with a floating share count of 108.20M. Insiders hold about 4.67% of the company’s shares, while institutions hold 75.12% stake in the company. Shares short for CHRS as of 1711584000 were 23447884 with a Short Ratio of 7.24, compared to 1709164800 on 24198890. Therefore, it implies a Short% of Shares Outstanding of 23447884 and a Short% of Float of 24.88.
Earnings Estimates
Currently, CHRG analysts are dedicated to thoroughly evaluating and rating the performance of Coherus Biosciences Inc (CHRS) in the stock market.The consensus estimate for the next quarter is $2.18, with high estimates of $1.69 and low estimates of $70.76.
